Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

This study has been completed.
Sponsor:
Collaborator:
Abbott
Information provided by (Responsible Party):
Vejle Hospital
ClinicalTrials.gov Identifier:
NCT01690598
First received: September 17, 2012
Last updated: June 9, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)